Tucows Inc. (LON:0LH4)

Regulus Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	138	151	231	304	662	574
Market Cap Growth	-9.97%	-34.76%	-23.99%	-54.12%	15.39%	16.39%
Enterprise Value	590	597	594	540	779	658
Last Close Price	12.81	12.75	20.46	24.48	66.75	45.33
PE Ratio	-	-	-	-	266.60	135.71
PS Ratio	0.48	0.52	0.87	1.14	2.95	2.52
PB Ratio	-1.64	-1.98	29.79	3.79	7.79	7.49
P/OCF Ratio	-	-	-	18.42	30.26	21.72
EV/Sales Ratio	2.12	2.07	2.23	2.03	3.47	2.89
EV/EBITDA Ratio	23.04	74.01	-	76.77	51.77	26.71
EV/EBIT Ratio	-	-	-	-	-	93.74
EV/FCF Ratio	-10.47	-	-	-	-	-
Debt / Equity Ratio	-5.89	-6.67	57.55	3.58	1.79	1.27
Debt / EBITDA Ratio	18.71	32.38	-	24.50	8.54	3.60
Asset Turnover	0.49	0.47	0.46	0.53	0.61	0.71
Inventory Turnover	47.58	43.95	32.76	40.47	80.67	78.99
Quick Ratio	0.32	0.39	0.58	0.26	0.16	0.15
Current Ratio	1.01	1.03	1.21	0.90	0.85	0.87
Return on Equity (ROE)	-	-	-180.60%	-26.04%	3.06%	5.81%
Return on Assets (ROA)	-1.68%	-2.80%	-5.03%	-3.23%	-0.96%	1.36%
Return on Capital (ROIC)	-2.36%	-3.90%	-7.20%	-5.09%	-1.70%	2.63%
Return on Capital Employed (ROCE)	-	-	-	-	-	3.30%
Earnings Yield	-55.32%	-58.24%	-32.70%	-7.53%	0.38%	0.74%
FCF Yield	-40.94%	-40.40%	-32.91%	-31.91%	-4.86%	-1.07%
Buyback Yield / Dilution	-0.93%	-0.95%	-0.88%	0.45%	-1.17%	0.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.